Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Journal of the American College of Cardiology|February 24, 2009
Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) studyPaul A Gurbel, Kevin P Bliden, Jorge F Saucedo, et al.
American Heart Journal|April 25, 2007
Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial diseasePaul Michael Grossman, Farrell Mendelsohn, Timothy D Henry, et al.
Thrombosis and Haemostasis|September 7, 2013
Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathwaysOscar Ö Braun, Dominick J Angiolillo, Jose L Ferreiro, et al.
Circulation|November 9, 2005
Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) RegistryJason W Ryan, Eric D Peterson, Anita Y Chen, et al.
Circulation. Cardiovascular Interventions|August 7, 2014
In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registryAkshay Bagai, Yongfei Wang, Tracy Y Wang, et al.
American Heart Journal|September 26, 2006
Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiativeManesh R Patel, Anita Y Chen, Eric D Peterson, et al.
Circulation. Cardiovascular Interventions|May 24, 2012
Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trialDominick J Angiolillo, Robert C Welsh, Dietmar Trenk, et al.
The American Journal of Cardiology|October 24, 2006
Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE)Pierluigi Tricoci, Eric D Peterson, Jyotsna Mulgund, et al.
JAMA|November 4, 2004
Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement InitiativeDeepak L Bhatt, Matthew T Roe, Eric D Peterson, et al.
Circulation|January 30, 2020
The American Heart Association 2030 Impact Goal: A Presidential Advisory From the American Heart AssociationSonia Y Angell, Michael V McConnell, Cheryl A M Anderson, et al.
Pageof 7